| Breakdown | TTM | Feb 2026 | Feb 2025 | Feb 2024 | Feb 2023 | Feb 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 49.84B | 49.64B | 49.13B | 44.36B | 43.13B | 40.49B |
| Gross Profit | 8.96B | 9.14B | 8.60B | 6.65B | 6.48B | 6.89B |
| EBITDA | 4.55B | 4.22B | 4.21B | 3.03B | 3.51B | 3.80B |
| Net Income | 2.03B | 2.18B | 2.01B | 1.06B | 1.29B | 1.47B |
Balance Sheet | ||||||
| Total Assets | 40.11B | 40.52B | 39.97B | 38.48B | 34.58B | 33.93B |
| Cash, Cash Equivalents and Short-Term Investments | 7.54B | 7.66B | 7.64B | 7.53B | 5.10B | 4.88B |
| Total Debt | 8.37B | 7.75B | 8.28B | 8.81B | 8.19B | 7.99B |
| Total Liabilities | 19.77B | 18.43B | 19.66B | 19.99B | 18.11B | 18.26B |
| Stockholders Equity | 19.35B | 21.03B | 19.31B | 17.57B | 15.40B | 14.33B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.15B | 1.19B | 2.37B | 329.96M | 1.78B |
| Operating Cash Flow | 0.00 | 2.55B | 2.35B | 3.46B | 1.55B | 3.34B |
| Investing Cash Flow | 0.00 | -1.27B | -1.16B | -2.53B | -775.72M | -1.63B |
| Financing Cash Flow | 0.00 | -1.28B | -1.24B | -32.69M | -683.88M | -782.85M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥1.28T | 11.76 | 7.04% | 1.47% | 3.37% | -31.10% | |
71 Outperform | ¥115.11B | 21.77 | 19.59% | 0.16% | 18.08% | 136.77% | |
68 Neutral | ¥40.78B | 7.42 | ― | 3.71% | -0.04% | 93.95% | |
66 Neutral | ¥9.31B | 2.00 | ― | 2.83% | 2.55% | 44.60% | |
64 Neutral | ¥16.83B | 8.16 | ― | 3.62% | 7.07% | 79.18% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
61 Neutral | ¥5.82B | -22.35 | ― | 2.72% | -1.30% | ― |